The World Cancer Immunotherapy Conference
25 - 26 Jan 2012
San Diego, CA, United States of America
The World Cancer Immunotherapy Conference is bringing together leading scientists and C-Level executives from across the globe to present research, case studies and viewpoints on various topics integral to a better understanding of the challenges and opportunities facing developers of therapeutic cancer vaccines.
With the recent commercialization of Provenge, an approval path has now been mapped out, albeit with major challenges in terms of uptake and reimbursement. Moreover, with other novel vaccines nearing approval, now is the time to revisit the successes and failures of this development program as well as the challenges that still lie ahead.
Topics and Themes
Speakers and panelists at this conference will discuss the following:
Cancer vaccine clinical trial design
FDA guidance for cancer vaccine developers and regulatory challenges
Biomarkers as an aid to clinical development of cancer vaccines
Optimal disease settings for cancer vaccine intervention
Cancer vaccines in combination therapies
No items were found.